Melanocyte protein PMEL;gp100;pmel 17
CAT No: ta-254
Synonyms/Alias:Melanocyte protein PMEL (177(8)-186); gp100(177(8)-186)
gp100(177(8)-186) is a synthetic peptide fragment derived from the human gp100 glycoprotein, a melanocyte differentiation antigen frequently studied in immunology, oncology, and peptide-based assay development. As a defined epitope sequence, this peptide serves as a valuable tool for dissecting antigen-specific cellular responses, particularly those involving T lymphocytes. Its well-characterized structure and immunological relevance have positioned it at the forefront of research into antigen processing, peptide-MHC binding, and immune recognition mechanisms, making it a preferred reagent in studies of tumor immunology and peptide-driven immune monitoring.
Antigen presentation research: The gp100(177(8)-186) peptide is widely utilized in investigations examining antigen processing and presentation pathways, particularly in the context of major histocompatibility complex (MHC) class I molecules. By loading this peptide onto antigen-presenting cells, researchers can precisely control the antigenic stimulus, enabling detailed analysis of peptide-MHC complex formation, stability, and recognition by cytotoxic T lymphocytes. Such studies are fundamental for elucidating the molecular determinants of immune specificity and the mechanisms by which epitopes are displayed to the adaptive immune system.
T cell activation assays: In cellular immunology, gp100(177(8)-186) serves as a robust reagent for evaluating antigen-specific T cell responses. Its defined sequence allows for the stimulation of T cells bearing cognate T cell receptors, facilitating the measurement of activation markers, cytokine secretion, and proliferation in vitro. This application is critical for mapping T cell repertoires, studying immune tolerance, and characterizing the functional properties of T cells in both basic and translational research settings.
Epitope mapping and immunogenicity studies: The peptide is instrumental in epitope mapping experiments aimed at identifying and characterizing immunodominant regions within the gp100 antigen. By incorporating this fragment into peptide libraries or using it as a probe in binding assays, scientists can delineate the fine specificity of antibody or T cell responses. These insights are essential for understanding the immunogenic landscape of melanocyte antigens and for informing the rational design of peptide-based immunological tools.
Peptide-MHC binding analyses: Researchers employ gp100(177(8)-186) in quantitative and qualitative studies of peptide-MHC interactions. Its sequence is a model substrate for determining binding affinities, kinetic parameters, and structural requirements for MHC class I association. Such data are crucial for refining computational prediction algorithms, validating in silico models, and advancing the field of immunopeptidomics, where accurate peptide-MHC pairing underpins both basic discovery and applied research.
Assay development and standardization: The consistent biochemical properties of this peptide make it an ideal standard for assay calibration and validation in immunological research. Whether used in ELISPOT, flow cytometry, or cytotoxicity assays, it provides a reproducible and well-characterized target for benchmarking assay performance, ensuring data comparability across experiments and laboratories. Its inclusion in assay development protocols supports the generation of reliable, high-quality data for immune monitoring and functional studies.
3. Emu oil in combination with other active ingredients for treating skin imperfections
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.